
-
Russian missile strike kills 14 in Ukraine leader's home city
-
Trump's tariff Big Bang puts global economy under threat
-
I Am Maximus backed for National as Mullins hot streak continues
-
2014 World Cup winner Hummels to retire at season's end
-
Intercommunal violence kills dozens in central Nigeria
-
Nigerian, S. African music saw 'extraordinary growth' in 2024: Spotify
-
Russell Brand: From Hollywood star to rape suspect
-
France soccer star Mbappe unveiled in London... in waxwork form
-
Trump goads China as global trade war escalates
-
Israel expands Gaza ground offensive, hits Hamas in Lebanon
-
TikTok faces new US deadline to ditch Chinese owner
-
US Fed Chair warns tariffs will likely raise inflation, cool growth
-
Mbappe among three Real Madrid players fined for 'indecent conduct'
-
How can the EU respond to Trump tariffs?
-
Canada loses jobs for first time in 3 years as US tariffs bite
-
Real Madrid and Barcelona respect each other, says Ancelotti
-
Nations divided ahead of decisive week for shipping emissions
-
Trump goads China after Beijing retaliates in global trade war
-
Arteta urges Arsenal to enjoy "beautiful" run-in despite injury woes
-
London mayor gets new powers to revive capital's ailing nightlife
-
Italy's ski star Brignone takes on 'new challenge' after serious leg injury
-
Amorim in a 'rush' to succeed at Man Utd
-
PSG coach Luis Enrique targets unbeaten season
-
Duterte victims seeking 'truth and justice': lawyer
-
US job growth strong in March but Trump tariff impact still to come
-
UK comedian and actor Russell Brand charged with rape
-
Stocks, oil slump as China retaliates and Trump digs in heels
-
Postecoglou 'falling out of love' with football due to VAR
-
EU hails 'new era' in relations with Central Asia
-
US hiring beats expectations in March as tariff uncertainty brews
-
'Unique' De Bruyne one of the greats, says Guardiola
-
Automakers shift gears after Trump tariffs
-
Where things stand in the US-China trade war
-
De Bruyne to leave Man City at end of the season
-
Youthful Matildas provide spark in friendly win over South Korea
-
Stocks, oil extend rout as China retaliates over Trump tariffs
-
De Bruyne says he will leave Man City at end of season
-
UK spy agency MI5 reveals fruity secrets in new show
-
Leverkusen's Wirtz to return 'next week', says Alonso
-
England bowler Stone to miss most of India Test series
-
Taiwan earmarks $2.7 bn to help industries hit by US tariffs
-
Rat earns world record for sniffing landmines in Cambodia
-
Elton John says new album 'freshest' since 1970s
-
EU announces 'new era' in relations with Central Asia
-
Greece nixes Acropolis shoot for 'Poor Things' director
-
'Historic moment': South Koreans react to Yoon's dismissal
-
Israel kills Hamas commander in Lebanon strike
-
Trump unveils first $5 million 'gold card' visa
-
Crashes, fires as Piastri fastest in chaotic second Japan GP practice
-
India and Bangladesh leaders meet for first time since revolution
RBGPF | 1.48% | 69.02 | $ | |
CMSC | -0.54% | 22.14 | $ | |
SCS | -1.13% | 10.62 | $ | |
NGG | -4.28% | 66.54 | $ | |
AZN | -6.68% | 69.29 | $ | |
RIO | -6.68% | 54.77 | $ | |
GSK | -6.12% | 36.76 | $ | |
RELX | -4.62% | 49.17 | $ | |
RYCEF | -16.39% | 8.42 | $ | |
BP | -9.29% | 28.675 | $ | |
JRI | -6.94% | 11.988 | $ | |
BCC | 0.23% | 94.85 | $ | |
CMSD | -0.09% | 22.65 | $ | |
BCE | 1.09% | 22.91 | $ | |
VOD | -9.72% | 8.54 | $ | |
BTI | -4.25% | 40.21 | $ |

Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
A.Jones--AMWN